LC
BVS icon

Lindbrook Capital’s Bioventus BVS Stock Holding History

Lindbrook Capital’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$458 Buy
50
+15
+43% +$150 ﹤0.01% 2636
2024
Q4 		$368 Hold
35
– – ﹤0.01% 2677
2024
Q3 		$418 Buy
+35
New +$303 ﹤0.01% 2711
2022
Q3 		– Sell
-232
Closed -$2K – 2636
2022
Q2 		$2K Buy
+232
New +$2.37K ﹤0.01% 1917

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lindbrook Capital's BVS Position: Q1 2025 in Review

Lindbrook Capital increased its Bioventus (BVS) stake by 43% in Q1 2025, buying an estimated $150 and bringing the position to 50 shares worth $458. The position accounts for ﹤0.01% of the portfolio, ranked #2636.

Lindbrook Capital first reported a position in BVS in Q2 2022 and has held it in 4 quarters since. The position peaked at $2K in Q2 2022. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • Lindbrook Capital held 50 shares of Bioventus worth $458 as of Q1 2025.
  • Lindbrook Capital bought 15 Bioventus shares in Q1 2025, an estimated $150.
  • Bioventus made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2636 holding.
  • Lindbrook Capital first reported a position in Bioventus in Q2 2022 and has held it in 4 quarters since.
  • Lindbrook Capital's Bioventus position peaked at $2K in Q2 2022.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.